X-linked chronic granulomatous disease
Clinical trials for X-linked chronic granulomatous disease explained in plain language.
Never miss a new study
Get alerted when new X-linked chronic granulomatous disease trials appear
Sign up with your email to follow new studies for X-linked chronic granulomatous disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
MRNA therapy gives immune cells a temporary boost against rare infection disease
Disease control Recruiting nowThis early-stage trial tests a new approach for chronic granulomatous disease (CGD), a genetic condition that leaves people vulnerable to severe infections. Researchers take a participant's own white blood cells, use mRNA to correct the genetic defect, and infuse the cells back. …
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Gene-Editing breakthrough aims to fix immune cells in rare disease
Disease control Recruiting nowThis early-stage trial tests a new gene-editing approach for X-linked chronic granulomatous disease (X-CGD), a rare immune disorder. Researchers will collect stem cells from 10 adult male participants, use base editing to correct the genetic mutation, and return the cells after m…
Matched conditions: X-LINKED CHRONIC GRANULOMATOUS DISEASE
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC